Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection

Infection and Drug Resistance

Volumn 7, Issue , 2014, Pages 57-62

  Leistner, Rasmus ^a   Sakellariou, Christian ^a   Gürntke, Stephan ^a   Kola, Axel ^a   Steinmetz, Ivo ^b   Kohler, Christian ^b   Pfeifer, Yvonne ^c   Eller, Christoph ^c   Gastmeier, Petra ^a   Schwab, Frank ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

BSI; ESBL genotype; Mortality; Sepsis

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 1; BETA LACTAMASE CTX M 15; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; DEMOGRAPHY; ENZYME SYNTHESIS; ESBL GENE; ESCHERICHIA COLI; FEMALE; GENE SEQUENCE; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MORTALITY; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 84897828988     PISSN: 11786973     EISSN: None     Source Type: Journal    
DOI: 10.2147/IDR.S56984     Document Type: Article

References (25)

1. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13(47): 19044.
2. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60(5):913-920.
3. Tumbarello M, Spanu T, Di Bidino R, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectr um-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54(10):4085-4091.
4. De Kraker ME, Wolkewitz M, Davey PG, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother. 2011;66(2):398-407.
5. Nasa P, Juneja D, Singh O, Dang R, Singh A. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome. Eur J Intern Med. 2012;23(2):192-195.
6. Stewardson A, Fankhauser C, De Angelis G, et al. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model. Infect Control Hosp Epidemiol. 2013;34(2):133-143.
7. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. Wayne (PA): CLSI; 2007
9. Gröbner S, Linke D, Schütz W, et al. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J Med Microbiol. 2009;58(Pt 7):912-922.
10. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153-2162.
11. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66(10):4555-4558.
12. Rodríguez-Baño J, Mingorance J, Fernández-Romero N, Serrano L, López-Cerero L, Pascual A. Outcome of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli: impact of microbiological determinants. J Infect. 2013;67(1):27-34.
13. Frakking FN, Rottier WC, Dorigo-Zetsma J W, et al. Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria. Antimicrob Agents Chemother. 2013;57(7):3092-3099.
14. Peralta G, Lamelo M, Alvarez-García P, et al. Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect Dis. 2012;12:245.
15. Cantón R, Akóva M, Carmeli Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413-431.
16. Rottier WC, Ammerlaan HS, Bonten MJ. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother. 2012;67(6): 1311-1320.
17. Rodríguez-Baño J, Picón E, Gijón P, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol. 2010;48(5): 1726-1731.
18. Kola A, Kohler C, Pfeifer Y, et al. High prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae in organic and conventional retail chicken meat, Germany. J Antimicrob Chemother. 2012;67(11):2631-2634.
19. Leistner R, Meyer E, Gastmeier P, Pfeifer Y, Eller C, Dem P, et al. Risk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia coli. An exploratory case-control study. PLoS One. 2013;8(9): e74323.
20. Ojer-Usoz E, González D, Vitas AI, et al. Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in meat products sold in Navarra, Spain. Meat Sci. 2013;93(2):316-321.
21. Nicolas-Chanoine MH, Blanco J, Lefon-Guibout V, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;61(2):273-281.
22. Voets GM, Platteel TN, Fluit AC, et al. Population distribution of beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in The Netherlands. PLoS One. 2012;7(12):e52102.
23. Reuland EA, Overdevest IT, Al Naiemi N, et al. High prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints. Clin Microbiol Infect. 2013;19(6):542-549.
24. Izdebski R, Baraniak A, Fiett J, et al. Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob Agents Chemother. 2013;57(1):309-316.
25. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin Microbiol Infect. 2012;18(7):646-655.